uniQure N.V. QURE
Set alert
24.83 USD -0.47 -1.86%
At close · Oct 30
26.51 +1.68 +6.77%
After hours · Oct 30, 7:56 PM ET
23.56 Day range 25.21
9.03 52-week range 67.86
- YTD
- +3.76%
- 1 year
- -63.41%
- Open
- 25.11
- Prev close
- 25.30
- Mkt cap
- 1.72B
- Vol
- 1.82M
- Avg vol
- 1.99M
- EPS
- -4.03
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 23.56
- High
- 25.21
- Forward P/E
- -8.36
- Beta
- 1.06
- Short ratio
- 2.55
- Inst. own
- 98.44%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 35.04
- 200-d avg
- 29.64
- 1y target
- 60.18
5D chart
Signals (133)
| Name | Time | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 30, 4:00 PM | 1 day ago |
| SMA: Bearish | Oct 30, 3:55 PM | 1 day ago |
| SMA: Bullish | Oct 30, 3:35 PM | 1 day ago |
| SMA: Bearish | Oct 30, 3:30 PM | 1 day ago |
| RSI: Overbought | Oct 30, 3:00 PM | 1 day ago |
| RSI: Overbought | Oct 30, 2:45 PM | 1 day ago |
| SMA: Bullish | Oct 30, 1:50 PM | 1 day ago |
| SMA: Bullish | Oct 30, 1:50 PM | 1 day ago |
| MACD: Buy Signal | Oct 30, 1:50 PM | 1 day ago |
| SMA: Bearish | Oct 30, 1:45 PM | 1 day ago |
| MACD: Sell Signal | Oct 30, 1:45 PM | 1 day ago |
| MACD: Buy Signal | Oct 30, 1:40 PM | 1 day ago |
| SMA: Bearish | Oct 30, 1:30 PM | 1 day ago |
| SMA: Bullish | Oct 30, 1:20 PM | 1 day ago |
| MACD: Sell Signal | Oct 30, 12:45 PM | 1 day ago |
| SMA: Bearish | Oct 30, 12:40 PM | 1 day ago |
| SMA: Bearish | Oct 30, 12:40 PM | 1 day ago |
| SMA: Bullish | Oct 30, 12:25 PM | 1 day ago |
| SMA: Bearish | Oct 30, 12:20 PM | 1 day ago |
| SMA: Bullish | Oct 30, 11:40 AM | 1 day ago |
| SMA: Bullish | Oct 30, 11:40 AM | 1 day ago |
| SMA: Bearish | Oct 30, 11:35 AM | 1 day ago |
| MACD: Buy Signal | Oct 30, 10:50 AM | 1 day ago |
| SMA: Bullish | Oct 30, 10:40 AM | 1 day ago |
| RSI: Oversold | Oct 30, 9:40 AM | 1 day ago |
| MACD: Sell Signal | Oct 30, 9:35 AM | 1 day ago |
| SMA: Bearish | Oct 30, 9:30 AM | 1 day ago |
| MACD: Buy Signal | Oct 29, 3:55 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 3:40 PM | 2 days ago |
| SMA: Bearish | Oct 29, 3:35 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:25 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 3:25 PM | 2 days ago |
| SMA: Bearish | Oct 29, 3:20 PM | 2 days ago |
| SMA: Bullish | Oct 29, 3:10 PM | 2 days ago |
| RSI: Oversold | Oct 29, 2:40 PM | 2 days ago |
| SMA: Bearish | Oct 29, 1:40 PM | 2 days ago |
| MACD: Sell Signal | Oct 29, 1:10 PM | 2 days ago |
| SMA: Bearish | Oct 29, 1:05 PM | 2 days ago |
| MACD: Buy Signal | Oct 29, 12:40 PM | 2 days ago |
| SMA: Bullish | Oct 29, 12:25 PM | 2 days ago |
| SMA: Bullish | Oct 29, 12:20 PM | 2 days ago |
| SMA: Bearish | Oct 29, 11:45 AM | 2 days ago |
| SMA: Bearish | Oct 29, 11:45 AM | 2 days ago |
| SMA: Bullish | Oct 29, 11:35 AM | 2 days ago |
| SMA: Bearish | Oct 29, 11:30 AM | 2 days ago |
| SMA: Bullish | Oct 29, 11:20 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:55 AM | 2 days ago |
| SMA: Bullish | Oct 29, 10:50 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:35 AM | 2 days ago |
| MACD: Sell Signal | Oct 29, 10:35 AM | 2 days ago |
| SMA: Bullish | Oct 29, 10:30 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:25 AM | 2 days ago |
| SMA: Bullish | Oct 29, 10:20 AM | 2 days ago |
| SMA: Bearish | Oct 29, 10:10 AM | 2 days ago |
| RSI: Overbought | Oct 29, 9:30 AM | 2 days ago |
| MACD: Buy Signal | Oct 28, 3:25 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:20 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:20 PM | 3 days ago |
| SMA: Bearish | Oct 28, 3:10 PM | 3 days ago |
| SMA: Bearish | Oct 28, 3:10 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:05 PM | 3 days ago |
| SMA: Bullish | Oct 28, 3:05 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 2:55 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 2:40 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:30 PM | 3 days ago |
| SMA: Bullish | Oct 28, 2:30 PM | 3 days ago |
| SMA: Bearish | Oct 28, 1:50 PM | 3 days ago |
| MACD: Sell Signal | Oct 28, 1:50 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:45 PM | 3 days ago |
| MACD: Buy Signal | Oct 28, 1:45 PM | 3 days ago |
| SMA: Bullish | Oct 28, 1:20 PM | 3 days ago |
| SMA: Bearish | Oct 28, 12:20 PM | 3 days ago |
| SMA: Bearish | Oct 28, 11:45 AM | 3 days ago |
| SMA: Bullish | Oct 28, 11:40 AM | 3 days ago |
| SMA: Bearish | Oct 28, 11:35 AM | 3 days ago |
| MACD: Sell Signal | Oct 28, 11:15 AM | 3 days ago |
| RSI: Overbought | Oct 28, 10:25 AM | 3 days ago |
| SMA: Bullish | Oct 28, 9:55 AM | 3 days ago |
| MACD: Buy Signal | Oct 28, 9:55 AM | 3 days ago |
| MACD: Sell Signal | Oct 28, 9:50 AM | 3 days ago |
| SMA: Bearish | Oct 28, 9:45 AM | 3 days ago |
| MACD: Buy Signal | Oct 27, 3:55 PM | 4 days ago |
| RSI: Overbought | Oct 27, 3:55 PM | 4 days ago |
| SMA: Bullish | Oct 27, 3:20 PM | 4 days ago |
| SMA: Bearish | Oct 27, 2:55 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 2:55 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 2:45 PM | 4 days ago |
| RSI: Overbought | Oct 27, 2:30 PM | 4 days ago |
| SMA: Bullish | Oct 27, 2:10 PM | 4 days ago |
| SMA: Bearish | Oct 27, 1:55 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 1:55 PM | 4 days ago |
| MACD: Buy Signal | Oct 27, 1:10 PM | 4 days ago |
| RSI: Overbought | Oct 27, 1:00 PM | 4 days ago |
| SMA: Bullish | Oct 27, 12:50 PM | 4 days ago |
| SMA: Bearish | Oct 27, 12:45 PM | 4 days ago |
| RSI: Overbought | Oct 27, 12:20 PM | 4 days ago |
| MACD: Sell Signal | Oct 27, 12:10 PM | 4 days ago |
| RSI: Overbought | Oct 27, 12:05 PM | 4 days ago |
| RSI: Overbought | Oct 27, 11:50 AM | 4 days ago |
| RSI: Overbought | Oct 27, 11:20 AM | 4 days ago |
| RSI: Overbought | Oct 27, 10:35 AM | 4 days ago |
| SMA: Bullish | Oct 27, 10:05 AM | 4 days ago |
| SMA: Bullish | Oct 27, 9:50 AM | 4 days ago |
| SMA: Bearish | Oct 27, 9:45 AM | 4 days ago |
| SMA: Bullish | Oct 27, 9:40 AM | 4 days ago |
| MACD: Buy Signal | Oct 27, 9:40 AM | 4 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 4 days ago |
| RSI: Oversold | Oct 27, 9:30 AM | 4 days ago |
| SMA: Bullish | Oct 26, 3:55 PM | 5 days ago |
| RSI: Oversold | Oct 26, 3:45 PM | 5 days ago |
| RSI: Oversold | Oct 26, 3:05 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 2:45 PM | 5 days ago |
| SMA: Bearish | Oct 26, 2:40 PM | 5 days ago |
| SMA: Bullish | Oct 26, 2:35 PM | 5 days ago |
| SMA: Bearish | Oct 26, 2:20 PM | 5 days ago |
| SMA: Bearish | Oct 26, 2:10 PM | 5 days ago |
| SMA: Bullish | Oct 26, 2:05 PM | 5 days ago |
| SMA: Bullish | Oct 26, 1:55 PM | 5 days ago |
| SMA: Bearish | Oct 26, 1:45 PM | 5 days ago |
| SMA: Bullish | Oct 26, 1:35 PM | 5 days ago |
| MACD: Buy Signal | Oct 26, 1:35 PM | 5 days ago |
| SMA: Bearish | Oct 26, 1:30 PM | 5 days ago |
| SMA: Bullish | Oct 26, 1:25 PM | 5 days ago |
| MACD: Sell Signal | Oct 26, 1:00 PM | 5 days ago |
| SMA: Bearish | Oct 26, 12:55 PM | 5 days ago |
| SMA: Bullish | Oct 26, 12:50 PM | 5 days ago |
| SMA: Bearish | Oct 26, 12:45 PM | 5 days ago |
| SMA: Bearish | Oct 26, 12:40 PM | 5 days ago |
| SMA: Bullish | Oct 26, 12:35 PM | 5 days ago |
| SMA: Bearish | Oct 26, 12:30 PM | 5 days ago |
| SMA: Bearish | Oct 26, 11:35 AM | 5 days ago |
| SMA: Bullish | Oct 26, 11:05 AM | 5 days ago |
| SMA: Bearish | Oct 26, 10:25 AM | 5 days ago |
Key statistics
- Market cap
- 1.72B
- Enterprise value
- 1.50B
- Trailing P/E
- 0.00
- Forward P/E
- -8.36
- PEG ratio
- 0.00
- Price / sales
- 92.24
- Price / book
- 5.31
- EPS (TTM)
- -4.03
- Beta
- 1.06
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 18.67M
- Revenue growth
- 11.00%
- Free cash flow
- -77.58M
- Total cash
- 810.33M
- Total debt
- 552.17M
- Return on equity
- -157.61%
- Shares outstanding
- 69.37M
- Short % of float
- 12.75%
- 50-day average
- 35.04
- 200-day average
- 29.64
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 60.18 +142.4% upside
Now 24.83
- Target (low)
- 27.90
- Target (mean)
- 60.18
- Target (high)
- 91.24
Ratings (0m) 13 11 buy · 2 hold · 0 sell
- Strong buy1
- Buy10
- Hold2
- Sell0
- Strong sell0
Next earnings
Nov 4, 2026
Expected Nov 4, 2026. Consensus EPS estimate -0.81964.
Financials — quick view
QURE Revenue — quarterly 5.84M
QURE Net income — quarterly -81.06M
QURE EPS — quarterly -1.22
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 4, 2026 | Sep 30, 2026 | -0.91521 | — | — | — |
| Jul 29, 2026 | Jun 30, 2026 | -0.82228 | -1.22 | -0.40 | -48.37% |
| May 5, 2026 | Mar 31, 2026 | -0.88 | -0.85 | +0.03 | +3.41% |
| Mar 2, 2026 | Dec 31, 2025 | -0.93 | -0.56 | +0.37 | +39.78% |
| Nov 10, 2025 | Sep 30, 2025 | -0.85 | -1.38 | -0.53 | -62.35% |
| Jul 29, 2025 | Jun 30, 2025 | -0.89 | -0.69 | +0.20 | +22.47% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 5, 2026 | Barclays | down | Overweight | Equal-Weight |
| Oct 2, 2026 | RBC Capital | main | Outperform | Outperform |
| Sep 30, 2026 | Goldman Sachs | main | Neutral | Neutral |
| Jul 30, 2026 | Wells Fargo | main | Overweight | Overweight |
| Jul 30, 2026 | Wolfe Research | up | Peer Perform | Outperform |
| Jul 30, 2026 | Barclays | main | Overweight | Overweight |
About uniQure N.V.
uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in Phase I/II clinical study for the treatment of Huntington's disease. The company also develops AMT-260, which is in Phase I/IIa clinical trial for the treatment of mesial temporal lobe epilepsy; AMT-162, which is in Phase I/IIa clinical trial to treat superoxide dismutase enzyme-amyotrophic lateral sclerosis; and AMT-191, an investigational gene therapy candidate which is in phase I/IIa clinical trial for the treatment of fabry disease. It has a licensing agreement with Apic Bio to develop, manufacture, and commercialize intrathecally administered investigational gene therapy for ALS caused by mutations in SOD-1; and development and commercial supply agreement with CLS Bhering. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Netherlands
- Website
- uniqure.com
News
- 3 Promising Genomics Stocks to Add to Your Portfolio Now
- uniQure to Announce Third Quarter 2026 Financial Results
- uniQure: The Market Graded The Wrong Exam
- uniQure N.V. Investigation Continues: Investors May Contact Kirby McInerney LLP, a Securities Fraud Law Firm, If You Lost Money On Your QURE Investments
- uniQure (NASDAQ:QURE) and Vir Biotechnology (NASDAQ:VIR) Critical Review
- Cedar Grove Capital Q3 2026 Portfolio Update
- UNIQURE N.V. QURE INVESTORS: Contact Kirby McInerney LLP About the Firm's Securities Investigation Following 37.3% Share Drop
- uniQure (NASDAQ:QURE) Stock Price Down 5.5% Following Analyst Downgrade
- Critical Survey: Alkermes (NASDAQ:ALKS) and uniQure (NASDAQ:QURE)
- uniQure (NASDAQ:QURE) Shares Gap Down on Analyst Downgrade
Your note
Sign in to keep a note on QURE — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ABI-SAAB WALID | Officer | Conversion of Exercise of derivative security | Jun 29, 2026 | 148,235 |
| BALACHANDRAN MADHAVEN | Director | Conversion of Exercise of derivative security | Jun 16, 2026 | 43,254 |
| JACQUES RACHELLE SUZANNE | Director | Sale | Jun 10, 2026 | 33,903 |
| KAPUSTA MATTHEW C | Chief Executive Officer | Conversion of Exercise of derivative security | Jul 1, 2026 | 519,227 |
| KLEMT CHRISTIAN | Chief Financial Officer | Stock Award(Grant) | Mar 3, 2026 | 226,581 |
| MEEK DAVID D | Director | Sale | Jun 10, 2026 | 39,747 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Avoro Capital Advisors LLC | 9.70% | 6,727,777 | 167.05M | Jun 29, 2026 |
| JPMORGAN CHASE & CO | 7.02% | 4,867,755 | 120.87M | Jun 29, 2026 |
| RTW Investments LP | 5.68% | 3,941,572 | 97.87M | Jun 29, 2026 |
| State Street Corporation | 4.19% | 2,903,825 | 72.10M | Jun 29, 2026 |
| Aberdeen Group plc | 4.11% | 2,848,117 | 70.72M | Jun 29, 2026 |
| Blackrock Inc. | 2.71% | 1,877,453 | 46.62M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.93% | 2,031,760 | 50.45M | Sep 29, 2026 |
| abrdn Healthcare Investors | 1.79% | 1,240,256 | 30.80M | Jun 29, 2026 |
| J.P. Morgan Mutual Fd. Investment TRT-JPMorgan Growth Advantage Fd. | 1.78% | 1,237,920 | 30.74M | Jun 29, 2026 |
| JPMorgan Trust II-JPMorgan Mid Cap Growth Fund | 1.38% | 959,052 | 23.81M | Jun 29, 2026 |
| abrdn World Healthcare Fund | 1.14% | 792,575 | 19.68M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.09% | 758,041 | 18.82M | Jun 29, 2026 |